trial · primary record
Apalutamide
Prostate Cancer
| Phase | Phase 3 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 74 |
| Primary completion | 2023-10-16 |
| Primary endpoint | Patient Preference Questionnaire |
| Registry ID | NCT04409288 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:39.325Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04409288
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.